Tech Company Financing Transactions
PhaseBio Pharmaceuticals Funding Round
PhaseBio Pharmaceuticals closed a $6.6 million investment round on 2/1/2017. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/1/2017
Transaction Type
Debt
Amount
$6,615,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Great Valley Pkwy. 30
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Not Recorded
Overview
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), located in Malvern, PA, is a development stage, privately held protein engineering company focused on developing the next generation of biopharmaceuticals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Mow
Chief Financial Officer
John Sharp
Chief Medical Officer
John Lee
VP - Bus. Development
Susan Arnold
VP - Bus. Development
Michael York
VP - R & D
James Ballance
Browse more venture capital transactions:
Prev: 2/1/2017: Ortho Kinematics venture capital transaction
Next: 2/1/2017: TeamSnap venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs